Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.
暂无分享,去创建一个
[1] E. Nabel,et al. Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. , 1989, Circulation.
[2] A. Becker,et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.
[3] P. Libby,et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.
[4] F J Pinto,et al. Nitroglycerin‐Induced Coronary Vasodilation in Cardiac Transplant Recipients: Evaluation With In Vivo Intracoronary Ultrasound , 1992, Circulation.
[5] A. Tajik,et al. Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. , 1995, Journal of the American College of Cardiology.
[6] H. Drexler,et al. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. , 1991, Circulation.
[7] M. Bell,et al. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. , 1995, Circulation.
[8] Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.
[9] P. Ganz,et al. Hypertension and Left Ventricular Hypertrophy Are Associated With Impaired Endothelium‐Mediated Relaxation in Human Coronary Resistance Vessels , 1993, Circulation.
[10] M. Sugimachi,et al. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. , 1993, The Journal of clinical investigation.
[11] A. Zeiher,et al. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. , 1995, Circulation.
[12] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[13] M. Hori,et al. Adenosine, the Heart, and Coronary Circulation , 1991, Hypertension.
[14] J. Stengård,et al. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease , 1994, The Lancet.
[15] J. Hodgson,et al. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. , 1994, Journal of the American College of Cardiology.
[16] S. Higano,et al. Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. , 1998, Circulation.
[17] P. Ganz,et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.
[18] D. Harrison,et al. The Nitrovasodilators New Ideas About Old Drugs , 1993, Circulation.
[19] H. M. Payne,et al. Validation of A Doppler Guide Wire for Intravascular Measurement of Coronary Artery Flow Velocity , 1992, Circulation.
[20] A. Tajik,et al. Erratum: Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound (J. Am. Coll. Cardiol. (1995) 26 (41-49)) , 1995 .
[21] Walter L. Henry,et al. Intravascular Ultrasound Imaging of Human Coronary Arteries In Vivo: Analysis of Tissue Characterizations With Comparison to In Vitro Histological Specimens , 1991, Circulation.
[22] R. Gibbons,et al. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. , 1997, Circulation.
[23] A. Heagerty,et al. Hyperlipidaemia, hypertension, and coronary heart disease , 1995, The Lancet.
[24] E. Nabel,et al. Responses of coronary arteries of cardiac transplant patients to acetylcholine. , 1988, The Journal of clinical investigation.
[25] D. Celermajer,et al. Endothelial dysfunction: does it matter? Is it reversible? , 1997, Journal of the American College of Cardiology.
[26] J. Myers,et al. Prevention of Coronary Heart Disease With Pravastatin in Men With Hypercholesterolemia , 1996 .
[27] E Fleck,et al. Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe). , 1997, Circulation.
[28] P. Tsao,et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. , 1998, Circulation.
[29] A. Yeung,et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. , 1990, Circulation.
[30] J. Albers,et al. Lipid Lowering and Plaque Regression New Insights Into Prevention of Plaque Disruption and Clinical Events in Coronary Disease , 1993, Circulation.
[31] M. Sugimachi,et al. Effects of Age on Endothelium‐Dependent Vasodilation of Resistance Coronary Artery by Acetycholine in Humans , 1993, Circulation.
[32] P. Tsao,et al. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. , 1992, The Journal of clinical investigation.